Spaces:
Runtime error
Runtime error
stock_news_summaries_AI
/
news
/BIIB
/2023.01.05
/Biogen splits R&D division ahead of key decision on Alzheimer's drug.txt
Jan 5 (Reuters) - Biogen Inc said on Thursday | |
it will split its research and development division into two | |
units ahead of a highly anticipated decision by the U.S. health | |
regulator about the company's second Alzheimer's drug.The company named interim R&D chief Priya Singhal as | |
executive vice president, head of development following the | |
separation.Singhal will also serve as the interim head of research till | |
the company completes its search for a new chief for that | |
division.Both Singhal and the new research head will report to Chief | |
Executive Officer Christopher Viehbacher, the former Sanofi SA | |
boss who was appointed after a months-long search to | |
replace Michel Vounatsos.The announcement comes as the company awaits the U.S. Food | |
and Drug Administration's decision for Biogen and Japanese | |
partner Eisai Co's Alzheimer's drug lecanemab. | |
(Reporting by Leroy Leo in Bengaluru; Editing by Shounak | |
Dasgupta) |